Webinar replay

Building a Business Development Powerhouse

Learn how Eli Lilly and Ipsen transformed their business development departments into powerhouses for partnerships.

This post is a panel discussion featuring expert insights from:
  • Tim Noblitt, Director, Corporate Business Development at Eli Lilly
  • Chris Vlahos, Global Head of Rare Disease External Innovation at Ipsen
Watch this replay to hear their insights and learn:
  • How to organize your external innovation team and manage their activities,
  • Strategies for finding external innovation - and how to be found if you have an asset or technology available for partnering,
  • Key metrics for evaluating and improving your performance,
  • How to accelerate business development and partnering.
Presented by:
Tim-Nobitt
Tim Noblitt
Director, Corporate Business Development
Eli Lilly
Chris-Vlahos
Chris Vlahos
Global Head of Rare Disease External Innovation
Ipsen

Please complete the form below

All fields marked with a * are required.

By submitting this form, you agree to the storing and processing of your
personal data by Inova as detailed in the Privacy Statement.

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 150 life science companies, including 50% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.